Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase …
…, T Pieber, R Prager, V Preumont, E Riffer… - The lancet Diabetes & …, 2019 - thelancet.com
Background Oral semaglutide is the first oral formulation of a glucagon-like peptide-1 (GLP-1)
receptor agonist developed for the treatment of type 2 diabetes. We aimed to compare the …
receptor agonist developed for the treatment of type 2 diabetes. We aimed to compare the …
[HTML][HTML] Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis …
…, C Molin, M Noss, L Kotek, M Reynolds, E Riffer… - Vaccine, 2018 - Elsevier
… Randomization was stratified by site, age group (18 to 39, 40 to 70 years), and type 2
diabetes mellitus status and performed centrally using an electronic interactive response system. …
diabetes mellitus status and performed centrally using an electronic interactive response system. …
Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind …
…, H Garcia, J Pouzar, M Seep, E Riffer… - The Lancet infectious …, 2017 - thelancet.com
Background Influenza continues to have a substantial socioeconomic and health impact
despite a long established vaccination programme and approved antivirals. Preclinical data …
despite a long established vaccination programme and approved antivirals. Preclinical data …
Randomized double-blind study comparing 3-and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial …
DC Henry, E Riffer, WN Sokol, NI Chaudry… - Antimicrobial agents …, 2003 - Am Soc Microbiol
A randomized, double-blind, multicenter study of adults with acute bacterial sinusitis (ABS)
compared the efficacy and safety of two azithromycin (AZM) regimens, 500 mg/day once daily …
compared the efficacy and safety of two azithromycin (AZM) regimens, 500 mg/day once daily …
Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women
DC Henry Jr, RB Bettis, E Riffer, DC Haverstock… - Clinical …, 2002 - Elsevier
Background: Trimethoprim/sulfamethoxazole (TMP/SMX) is currently the first choice for
empiric therapy of acute uncomplicated urinary tract infection (UTI) in women. In areas where …
empiric therapy of acute uncomplicated urinary tract infection (UTI) in women. In areas where …
A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired …
MH Gotfried, D Dattani, E Riffer, KJ Devcich… - Clinical …, 2002 - Elsevier
Background: Macrolides and fluoroquinolones are frequently used for the empiric treatment
of community-acquired pneumonia (CAP). Objective: The aim of the study was to compare …
of community-acquired pneumonia (CAP). Objective: The aim of the study was to compare …
Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial
…, JE Pappas, K Patrick, SJ Powell, E Riffer… - Journal of clinical …, 2015 - Elsevier
Background In the Determining the Efficacy and Tolerability of cholesteryl ester transfer protein
(CETP) INhibition with AnacEtrapib (DEFINE) trial, anacetrapib added to statin produced …
(CETP) INhibition with AnacEtrapib (DEFINE) trial, anacetrapib added to statin produced …
Once daily clarithromycin extended-release vs twice-daily amoxicillin/clavulanate in patients with acute bacterial sinusitis: a randomized, investigator-blinded study
E Riffer, J Spiller, R Palmer, V Shortridge… - … medical research and …, 2005 - Taylor & Francis
… Marchi E. Comparative efficacy and tolerability of clarithromycin and amoxycillin in the
treatment of outpatients with acute maxillary sinusitis. Curr Med Res Opin 1990;12:19-24 19. …
treatment of outpatients with acute maxillary sinusitis. Curr Med Res Opin 1990;12:19-24 19. …
Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis
…, R Bettis, ZM Munk, H Fleming, NJ Munn, E Riffer… - Clinical …, 1999 - Elsevier
Three hundred eighty-nine patients were enrolled in a double-masked, multicenter,
randomized clinical trial comparing the clinical and bacteriologic efficacies and safety of a 5-day …
randomized clinical trial comparing the clinical and bacteriologic efficacies and safety of a 5-day …
Successful treatment with antivenin of marked thrombocytopenia without significant coagulopathy following rattlesnake bite.
We cared for two rattlesnake bite victims who developed platelet counts of 21,000/mm3 and
22,000/mm3. Both had only mild defibrination without evidence of intravascular clotting. In …
22,000/mm3. Both had only mild defibrination without evidence of intravascular clotting. In …